Patanjali, launched two ayurvedic medicines Coronil and Swasari Vati. The company claims that clinical trials of the medication yielded 100 per cent favourable results in COVID-19 positive patients
Baba Ramdev launched the world’s first Ayurvedic medicine for treating COVID-19 in patients. The company claims that the product is not just an immunity booster but cures those with COVID-19.
On Tuesday, Patanjali, launched two medicines Coronil and Swasari Vati and claimed that the clinical trials of the medication had yielded 100 per cent favourable results in COVID-19 positive patients.
“The whole country and the world was waiting for medicine or vaccine for coronavirus. We are proud to announce that the first Ayurvedic, clinically controlled trial based evidence and research-based medicine has been prepared by the combined efforts of Patanjali Research Centre and NIMS,” said Baba Ramdev at a press conference in Haridwar. He also added that clinical trials of the medicine has shown “100 per cent recovery rate within 3-7 days.”
“We are launching COVID medicines Coronil and Swasari today. We conducted two trials of these, first clinical controlled study, which took place in Delhi, Ahmedabad, among many other cities. Under this, 280 patients were included and 100 per cent of those recovered. We were able to control coronavirus and its complications in this. After this, the all-important clinical control trial was conducted,” he further said.
The corona kit will be available in the market for just Rs 545, informed Patanjali CEO, Acharya Balkrishna.
“This medicine kit is not available anywhere for now and will be made available at Patanjali stores in a week,” said Baba Ramdev while speaking to the media. An app will also be launched to facilitate the delivery of corona kit to customers.
Baba Ramdev also said that all the necessary approvals for conducting trials on patients were taken from competent authorities during the research.